Paolo Ghia

37.0k citations
399 papers · 12.7k indexed · 7 hit papers · h-index 60

Paolo Ghia

378 papers receiving 12.6k citations

Hit Papers

Chronic lymphocytic leukaemia: ESMO Clinical Practice Gui...201520262018202220152020201920202022100200300400

Peers

Paolo Ghia
Comparison fields: 5 of 130
  • Genetics 8.8k
  • Pathology and Forensic Medicine 6.4k
  • Immunology 6.0k
  • Molecular Biology 2.6k
  • Oncology 2.5k
Replace Federico Caligaris‐Cappio with:
Federico Caligaris‐Cappio Italy
Richard R. Furman United States
Emili Montserrat Spain
Jan A. Burger United States
John C. Byrd United States
David Oscier United Kingdom
Francesc Bosch Spain
Davide Rossi Italy
Jonathan E. Kolitz United States
Armando López‐Guillermo Spain
Paolo Ghia relative to Federico Caligaris‐Cappio Italy Federico Caligaris‐Cappio's profile →
Citations per field
00.5×10×16×
Federico Caligaris‐Cappio · 1×
Citations per year

Countries citing papers authored by Paolo Ghia

Since Specialization
Citations

This map shows the geographic impact of Paolo Ghia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ghia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ghia more than expected).

Fields of papers citing papers by Paolo Ghia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Ghia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ghia. The network helps show where Paolo Ghia may publish in the future.

Co-authorship network of co-authors of Paolo Ghia

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Ghia. A scholar is included among the top collaborators of Paolo Ghia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Ghia. Paolo Ghia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 5
3 14
4 2
5 4
6 10
7 1
8 6
9 1
10 6
11 6
12 47
13 20
14 33
15
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemiabreakdown →
252
16 63
17
Ex Vivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity For Idelalisib And Ibrutinib On Cll Cells
1
18 33
19 37
20 28

About Paolo Ghia

Paolo Ghia is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 399 papers that have together received 12.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (343 papers), Lymphoma Diagnosis and Treatment (190 papers) and Immunodeficiency and Autoimmune Disorders (97 papers). The work is most often cited by research in Genetics (8.8k citations), Pathology and Forensic Medicine (6.4k citations) and Immunology (6.0k citations). Paolo Ghia has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Federico Caligaris‐Cappio, Cristina Scielzo, Lydia Scarfò, Κώστας Σταματόπουλος, Peter Hillmen, Jan A. Burger, Tadeusz Robak, Massimo Geuna, Michael Hallek and Marta Muzio. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026